Keyphrases
Breast Tumor
100%
Tumor Antigen
100%
Neoepitope
100%
T Cell Receptor
38%
Breast Cancer
30%
Immunogenic
23%
Mutation Specific
23%
TP53 mutation
23%
Specific T Cells
23%
CD8+ T Cells
23%
PIK3CA mutation
23%
PIK3CA
23%
Specific Intent
23%
B Cells
15%
Epitope
15%
CD40 Ligand (CD40L)
15%
RNA Expression
15%
Immunogenicity
15%
Biochemical Verification
15%
Triple-negative Breast Cancer
15%
Breast Cancer Vaccine
15%
T Cell Epitope
15%
Breast Cancer Treatment
15%
Clinical Trials
15%
Mutant Protein
7%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
7%
Mutated Antigen
7%
HLA multimer
7%
Fluorescence-activated Cell Sorting
7%
Cells Chain
7%
Neopeptide
7%
Breast Cancer Genomics
7%
Breast Cancer Cell Lines
7%
Neoadjuvant
7%
Cancer Antigen
7%
Cell Donors
7%
Pipeline Strategy
7%
Exome Sequencing
7%
Predictive Biomarker
7%
Mutated Genes
7%
MRNA Level
7%
Anti-PD-1 Therapy
7%
Chimeric Antigen Receptor T Cells (CAR-T)
7%
Hotspot mutation
7%
Missense mutation
7%
Tumor mutation Burden
7%
IRB Approval
7%
Prediction Model
7%
Proteomics
7%
Cell Line-derived Xenograft
7%
Specific Immunity
7%
Optimal Target
7%
Retroviral Vector
7%
Cellular Immune Response
7%
HLA Class I
7%
Cancer Vaccine
7%
Target Antigen
7%
Immunome
7%
Advanced Triple-negative Breast Cancer
7%
Peptide Binding Prediction
7%
Artificial Neural Network (ANN) Model
7%
Tumor Cell Lines
7%
Hydrophobicity
7%
Checkpoint Blockade Immunotherapy
7%
Checkpoint Blockade
7%
ER +
7%
Antigenic Peptide
7%
Informatics pipeline
7%
Nonsynonymous
7%
Multiple Tumors
7%
Patient-derived Tumor Xenograft
7%
Cell Sorter
7%
Immune Monitoring
7%
I-SPY
7%
Functional Specificity
7%
Cancer-specific
7%
T Cell Immunotherapy
7%
Complementarity-determining Region 3 (CDR3)
7%
Adoptive Cell Therapy
7%
Bioinformatics pipeline
7%
Oncogenesis
7%
Healthy Donors
7%
T Cell Lines
7%
Expression Vector
7%
K562
7%
Antigen-specific
7%
HLA Typing
7%
Biomarkers of Response
7%
Receptor Targets
7%
Data Development
7%
Patient-derived Xenograft
7%
Patient-specific
7%
Quantitative PCR
7%
Informatics
7%
Proteome
7%
Flow Cytometry
7%
Binding Affinity
7%
Mathematical Modeling
7%
Mass Spectrometry
7%
T Cells
7%
Overall Response Rate
7%
Response Rate
7%
Breast Cancer Subtypes
7%
RNA Sequencing (RNA-seq)
7%
Bioscience
7%
Hydro
7%
Clinical Response
7%
Experimental Validation
7%
Viral
7%
Welcome
7%
Breast
7%
Tumor
7%
Bioinformatics
7%
Medicine and Dentistry
Tumor Antigen
100%
Immunotherapy
100%
Breast Cancer
100%
Epitope
77%
Protein P53
38%
T Cell
33%
T Lymphocyte Receptor
27%
Neoplasm
22%
Triple Negative Breast Cancer
16%
Cytotoxic T-Cell
16%
Tumor Vaccine
16%
CD40 Ligand
11%
Tetramer
11%
Immunogenicity
11%
Cancer Immunotherapy
11%
B Cell
11%
Clinical Trial
11%
Cell Line
11%
Tumor Cell Line
5%
Tandem Mass Spectrometry
5%
Arsphenamine
5%
Xenograft
5%
Tumor Mutation Burden
5%
Carcinogenesis
5%
Reverse Transcription Polymerase Chain Reaction
5%
RNA Sequence
5%
Retrovirus Vector
5%
Cell Therapy
5%
Proteus Syndrome
5%
Breast Cancer Cell Line
5%
HLA Typing
5%
Cellular Immunity
5%
Fluorescence Activated Cell Sorting
5%
T Cell Receptor
5%
Polymer
5%
Liquid Chromatography-Mass Spectrometry
5%
Expression Vector
5%
Breast Tumor
5%
Adaptive Immunity
5%
Missense Mutation
5%
Tumor Xenograft
5%
Chimeric Antigen Receptor T-Cell
5%
Biological Marker
5%
Proteomics
5%
Flow Cytometry
5%
Exome Sequencing
5%
Proteome
5%
Binding Affinity
5%
Mass Spectrum
5%
Immunity
5%
Immunology and Microbiology
Epitope
100%
Tumor Antigen
100%
Immunotherapy
100%
P53
50%
T Cell Receptor
42%
T Cell
42%
Peptides
28%
Cytotoxic T-Cell
21%
Tumor Vaccine
21%
Cancer Immunotherapy
14%
Xenograft
14%
Immunogenicity
14%
B Cell
14%
CD40 Ligand
14%
Bioinformatics
14%
Cell Line
14%
Fluorescence Activated Cell Sorting
7%
RNA Sequence
7%
Adaptive Immune System
7%
Artificial Neural Network
7%
Retrovirus Vector
7%
Reverse Transcription Polymerase Chain Reaction
7%
Tandem Mass Spectrometry
7%
Missense Mutation
7%
Breast Cancer Cell Line
7%
Liquid Chromatography Mass Spectrometry
7%
Whole Exome Sequencing
7%
Expression Vector
7%
Binding Affinity
7%
Adoptive Immunity
7%
Chimeric Antigen Receptor T-Cell
7%
Tumor Cell Line
7%
HLA Typing
7%
Hydrophobicity
7%
Proteomics
7%
Immunity
7%